We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
-11.86%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.99%
AUM
$3.9B
AUM Growth
-$494M
Cap. Flow
+$90.4M
Cap. Flow %
2.32%
Top 10 Hldgs %
30.67%
Holding
1,195
New
117
Increased
183
Reduced
261
Closed
98

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$30.2M
2
DHI icon
D.R. Horton
DHI
+$23M
3
HD icon
Home Depot
HD
+$15.2M
4
AAPL icon
Apple
AAPL
+$13.8M
5
LRCX icon
Lam Research
LRCX
+$8.4M

Top Sells

Rank Stock Value
1
AXP icon
American Express
AXP
+$17.4M
2
SPGI icon
S&P Global
SPGI
+$11.4M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$7.54M
4
LH icon
Labcorp
LH
+$6.36M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$3.78M

Sector Composition

Rank Sector Weight
1 Technology 25.58%
2 Healthcare 20.75%
3 Financials 11.38%
4 Miscellaneous 10.22%
5 Consumer Discretionary 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGNC icon
901
AGNC Investment
AGNC
$12.5B
$4K ﹤0.01%
+355
New +$4.21K
BFAM icon
902
Bright Horizons
BFAM
$3.2B
$4K ﹤0.01%
+45
New +$4.47K
BLUE
903
DELISTED
bluebird bio
BLUE
$4K ﹤0.01%
50
– –
CFR icon
904
Cullen/Frost Bankers
CFR
$10.1B
$4K ﹤0.01%
+34
New +$4.34K
DLB icon
905
Dolby
DLB
$5.79B
$4K ﹤0.01%
+61
New +$4.61K
ESGD icon
906
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.1B
$4K ﹤0.01%
+58
New +$3.96K
FSLR icon
907
First Solar
FSLR
$21.8B
$4K ﹤0.01%
60
– –
GMED icon
908
Globus Medical
GMED
$10B
$4K ﹤0.01%
+66
New +$4.34K
HIMX
909
Himax Technologies
HIMX
$2.43B
$4K ﹤0.01%
540
– –
ILMN icon
910
Illumina
ILMN
$31B
$4K ﹤0.01%
22
+1
+5% +$255
STEM icon
911
Stem
STEM
$51.7M
$4K ﹤0.01%
25
-14
-36% -$2.33K
SWK icon
912
Stanley Black & Decker
SWK
$13.8B
$4K ﹤0.01%
36
+35
+3,500% +$4.31K
TAK icon
913
Takeda Pharmaceutical
TAK
$58.2B
$4K ﹤0.01%
286
– –
TSVT
914
DELISTED
2seventy bio
TSVT
$4K ﹤0.01%
333
– –
TYG
915
Tortoise Energy Infrastructure Corp
TYG
$917M
$4K ﹤0.01%
+125
New +$4.09K
VRTX icon
916
Vertex Pharmaceuticals
VRTX
$132B
$4K ﹤0.01%
15
+3
+25% +$803
LEV
917
DELISTED
The Lion Electric Company
LEV
$4K ﹤0.01%
1,000
– –
IMGN
918
DELISTED
Immunogen Inc
IMGN
$4K ﹤0.01%
810
– –
TRTN
919
DELISTED
Triton International Limited
TRTN
$4K ﹤0.01%
83
– –
FABC
920
Fabric.AI Inc
FABC
$17.2M
$3K ﹤0.01%
30
– –
CAH icon
921
Cardinal Health
CAH
$55.8B
$3K ﹤0.01%
65
+50
+333% +$2.84K
CBSH icon
922
Commerce Bancshares
CBSH
$8.33B
$3K ﹤0.01%
+55
New +$3.09K
CC icon
923
Chemours
CC
$2.26B
$3K ﹤0.01%
100
– –
DGT icon
924
State Street SPDR Global Dow ETF
DGT
$639M
$3K ﹤0.01%
36
– –
HMC icon
925
Honda
HMC
$40.6B
$3K ﹤0.01%
140
– –
35 36
37
38 39

Similar funds

O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

HM Payson & Co's Q2 2022 Portfolio in Review

As of Q2 2022, HM Payson & Co held 1,195 positions worth $3.9B, down 11% from $4.39B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HM Payson & Co's Q2 2022 filing shows 117 new, 183 increased, 261 reduced and 98 closed positions. Its largest new stake was ESAB: 33,218 shares worth $1.45M. The largest sale was American Express, an estimated $17.4M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2022 buy was ESAB: 33,218 shares worth $1.45M.
  • HM Payson & Co added most to Chevron in Q2 2022, an estimated $30.2M increase.
  • HM Payson & Co's biggest Q2 2022 reduction was American Express, cutting an estimated $17.4M.
  • HM Payson & Co fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $1.23M.
  • HM Payson & Co's ten largest holdings make up 31% of its $3.9B portfolio in Q2 2022.
  • HM Payson & Co opened 117 new positions and closed 98 in Q2 2022.
  • HM Payson & Co's portfolio value fell 11% quarter-over-quarter to $3.9B.

Based on HM Payson & Co's 13F filing for Q2 2022, filed 15 Aug 2022.